Literature DB >> 26440465

Defined daily dose (DDD) and its potential use in clinical trials of resistant hypertension.

Rodrigo Modolo1, Ana Paula de Faria2, Alessandra M V Ritter2, Antonio Coca3, Heitor Moreno2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26440465     DOI： 10.1016/j.ijcard.2015.09.096

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

1.  Treatment Intensity, Prescribing Patterns, and Blood Pressure Control in Rural Black Patients with Uncontrolled Hypertension.

Authors:  Doyle M Cummings; Alyssa Adams; Shivajirao Patil; Andrea Cherrington; Jacqueline R Halladay; Suzanne Oparil; Orysya Soroka; Joanna Bryan Ringel; Monika M Safford
Journal:  J Racial Ethn Health Disparities       Date:  2022-10-21

2.  Relationship between doses of antihypertensive drugs and left ventricular mass index changes in hemodialysis patients in a Japanese cohort.

Authors:  Fumiya Kitamura; Makoto Yamaguchi; Takayuki Katsuno; Hironobu Nobata; Shiho Iwagaitsu; Hirokazu Sugiyama; Hiroshi Kinashi; Shogo Banno; Masahiko Ando; Yoko Kubo; Yasumasa Kawade; Iwashima Shigejiro; Yutaka Ito; Takuji Ishimoto; Yasuhiko Ito
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

3.  Efficacy of "Pinggan Formula" in Controlling Acute Type B Aortic Dissection Perioperative Blood Pressure: A Randomized Controlled Clinical Trial.

Authors:  Hao Zhang; Danying Zhang; Yudong Sun; Ye Lu; Jiaxuan Feng; Lei Zhang; Chao Song; Zaiping Jing; Chaoqin Yu; Qingsheng Lu
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-15       Impact factor: 2.629
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.